AMBBY (Ambu AS) Dividends Received


AMBBY Ambu AS AMBBY
86 GF Score
Price $9.70
GF Value $19.34
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

AMBBY
86GF Score
Ambu AS AMBBY
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ambu AS (AMBBY) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of $9.70 is trading 49.8% below its estimated GF Value™ of $19.34. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for AMBBY:

  • Dividends Received:
  • GF Value™: $19.34 vs. price of $9.70 (49.8% below fair value)
  • GF Score™: 86/100

No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
86GF Score

Get the complete analysis for AMBBY

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.70
Price
$19.34
GF Value